Parkinson's disease α-synuclein mutations exhibit defective axonal transport in cultured neurons
Author:
Saha Anirban R.1, Hill Josephine1, Utton Michelle A.1, Asuni Ayodeji A.1, Ackerley Steven1, Grierson Andrew J.1, Miller Christopher C.1, Davies Alun M.2, Buchman Vladimir L.2, Anderton Brian H.1, Hanger Diane P.1
Affiliation:
1. Department of Neuroscience, PO Box 38, Institute of Psychiatry, King's College London, De Crespigny Park, London, SE5 8AF, UK 2. Department of Preclinical Veterinary Sciences, Royal (Dick) School of Veterinary Studies, Edinburgh, EH9 1QH, UK
Abstract
α-Synuclein is a major protein constituent of Lewy bodies and mutations in α-synuclein cause familial autosomal dominant Parkinson's disease. One explanation for the formation of perikaryal and neuritic aggregates of α-synuclein, which is a presynaptic protein, is that the mutations disrupt α-synuclein transport and lead to its proximal accumulation. We found that mutant forms of α-synuclein, either associated with Parkinson's disease (A30P or A53T) or mimicking defined serine, but not tyrosine, phosphorylation states exhibit reduced axonal transport following transfection into cultured neurons. Furthermore, transfection of A30P, but not wild-type, α-synuclein results in accumulation of the protein proximal to the cell body. We propose that the reduced axonal transport exhibited by the Parkinson's disease-associated α-synuclein mutants examined in this study might contribute to perikaryal accumulation of α-synuclein and hence Lewy body formation and neuritic abnormalities in diseased brain.
Publisher
The Company of Biologists
Reference51 articles.
1. Ackerley, S., Grierson, A. J., Brownlees, J., Thornhill, P., Anderton, B. H., Leigh, P. N., Shaw, C. E. and Miller, C. C. (2000). Glutamate slows axonal transport of neurofilaments in transfected neurons. J. Cell Biol.150, 165-176. 2. Ackerley, S., Thornhill, P., Grierson, A. J., Brownlees, J., Anderton, B. H., Leigh, P. N., Shaw, C. E. and Miller, C. C. (2003). Neurofilament heavy chain side arm phosphorylation regulates axonal transport of neurofilaments. J. Cell Biol.161, 489-495. 3. Antonsson, B., Kassel, D. B., di Paolo, G., Lutjens, R., Riederer, B. M. and Grenningloh, G. (1998). Identification of in vitro phosphorylation sites in the growth cone protein SCG10. Effect of phosphorylation site mutants on microtubule-destabilizing activity. J. Biol. Chem.273, 8439-8446. 4. Bonvini, P., An, W. G., Rosolen, A., Nguyen, P., Trepel, J., Garcia, d. H., Dunach, M. and Neckers, L. M. (2001). Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription. Cancer Res.61, 1671-1677. 5. Braak, H., Sandmann-Keil, D., Gai, W. and Braak, E. (1999). Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry. Neurosci. Lett.265, 67-69.
Cited by
147 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|